Tumors of the Brain and Spine (M. D. Anderson Cancer Care Series)

個数:

Tumors of the Brain and Spine (M. D. Anderson Cancer Care Series)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 400 p./サイズ 87 illus.
  • 言語 ENG
  • 商品コード 9780387292014
  • DDC分類 616

基本説明

Focuses primarily on the standard approaches to the treatment of benign, primary low-grade to high-grade, and metastatic tumors in the brain and spine used by surgeons and clinicians at The University of Texas M. D. Anderson Cancer Center.

Full Description

It is frequently stated that progress in the management of tumors of the brain and spine has not occurred in the past 25 years. Such statements seriously underestimate and misrepresent progress in managing various central nervous system tumors, the tremendous technologic enhancements that have revolutionized the imaging of the tumors and the host organ, the multitude of surgical adjuncts such as computerized imaging guidance and functional mapping of the brain and its tracts that are routinely used in the modern neurosurgical operating room, and the highly conformal delivery of radiation to the tumor mass with remarkable sparing of the surrounding nervous tissue. Underlying these technologic improvements are the changes in philosophy that have resulted in a true multidisciplinary approach. Equally significant is the molecular revolution that is identifying key markers behind the genesis of brain tumors, their proliferation, and their resistance to therapy. These molecular discoveries have ushered in the era of molecular targeted therapy, as first demonstrated by the extraordinary success story in chronic myelogenous leukemia of imatinib (Gleevec). The rational combination of targeted agents will revolutionize the way che- therapy is given, either alone or in conjunction with radiotherapy. Lastly, focused attention to patients' well-being has emphasized all measures of quality of life, has encouraged greater participation by patients and their caregivers in the decision-making process, and has encouraged the development of a variety of quality-of-life measurement tools to ensure that adverse effects of treatment are recognized and addressed.

Contents

Epidemiology of Brain Tumors.- Neuropathology and Molecular Biology of Intracranial Tumors.- Radiology of Brain Tumors: Structure and Physiology.- Surgically Curable Brain Tumors of Adults.- Low-Grade Gliomas: Evidence-Based Treatment Options.- Surgical Strategies for High-Grade Gliomas.- Radiation Oncology for Tumors of the Central Nervous System: Improving the Therapeutic Index.- Cytotoxic Chemotherapy for Diffuse Gliomas.- Innovative Treatment Strategies for High-Grade Gliomas.- Pituitary Tumors in Oncology.- Management of Lung Cancer, Breast Cancer, and Melanoma Metastatic to the Brain.- Neoplastic Meningitis.- Lymphoma Affecting the Central Nervous System.- Tumors of the Extradural Spine.- Tumors of the Spinal Cord and Intradural Space.- Symptom Management for Patients with Brain Tumors: Improving Quality of Life.

最近チェックした商品